Prevalence of Metabolic Syndrome Among Patients with Type 2 Diabetes at the Bon Samaritain University Hospital Complex in N’Djamena, Chad

Authors

  • Suitambaye Noubaramadji Yamti Laboratoire des Grandes Épidémies Tropicales, Bon Samaritain University Hospital Complex, N’Djamena, Chad; Faculty of Sciences and Technologies of the Evangelical University of Cameroon, Mbouo-Bandjoun, Cameroon
  • Abel Dafogo Djibagaou Laboratoire des Grandes Épidémies Tropicales, Bon Samaritain University Hospital Complex, N’Djamena, Chad; Faculty of Sciences and Technologies of the Evangelical University of Cameroon, Mbouo-Bandjoun, Cameroon; Faculty of Medicine, Bon Samaritain University Hospital Complex, N’Djamena, Chad
  • Koutaya Dezoumbe Laboratoire des Grandes Épidémies Tropicales, Bon Samaritain University Hospital Complex, N’Djamena, Chad; Faculty of Sciences and Technologies of the Evangelical University of Cameroon, Mbouo-Bandjoun, Cameroon; Faculty of Medicine, Bon Samaritain University Hospital Complex, N’Djamena, Chad
  • Amine Akouya Laboratoire des Grandes Épidémies Tropicales, Bon Samaritain University Hospital Complex, N’Djamena, Chad; Faculty of Sciences and Technologies of the Evangelical University of Cameroon, Mbouo-Bandjoun, Cameroon
  • Zita Aleyo Nodjikouambaye Laboratoire des Grandes Épidémies Tropicales, Bon Samaritain University Hospital Complex, N’Djamena, Chad
  • Andrillene Laure Deutou Wondeu Laboratoire des Grandes Épidémies Tropicales, Bon Samaritain University Hospital Complex, N’Djamena, Chad; Faculty of Sciences and Technologies of the Evangelical University of Cameroon, Mbouo-Bandjoun, Cameroon
  • Brahim Boy Otchom Toumaï University, N’Djamena, Chad
  • Sabrina Atturo Laboratoire des Grandes Épidémies Tropicales, Bon Samaritain University Hospital Complex, N’Djamena, Chad
  • Giulia Cappelli Laboratoire des Grandes Épidémies Tropicales, Bon Samaritain University Hospital Complex, N’Djamena, Chad; Laboratory of Immunology, National Research Council, Rome, Italy
  • Vittorio Colizzi Laboratoire des Grandes Épidémies Tropicales, Bon Samaritain University Hospital Complex, N’Djamena, Chad; Faculty of Medicine, Bon Samaritain University Hospital Complex, N’Djamena, Chad

DOI:

https://doi.org/10.26555/eshr.v7i2.12641

Keywords:

Metabolic Syndrome, Abdominal Obesity, Hypertension, Chad

Abstract

Introduction: The Metabolic Syndrome (MS) is characterized by the presence of at least three of the following five factors: abdominal obesity, hypertriglyceridemia, low HDL-cholesterol, glucose intolerance or type 2 diabetes, hypertension. It is relatively common with a prevalence that increases with age and predisposes to the occurrence of cardiovascular complications, hence the motivation of this study, the aim of which was to determine its prevalence in a Chadian population.

Method: We conducted a prospective study involving 115 subjects aged 20 to 80 received at the Biochemistry laboratory as part of a monthly visit. The anthropometric and clinical data were recorded, and the biochemical parameters were analyzed on the PENTRA C400 automaton. The MS was defined according to the criteria of the NCEP-ATP III (2001). All of these data were analyzed using Excel 2013 and IBM SPSS software.

Results: in our study the prevalence of MS is 72.2% of cases with a female predominance of 86.15% and it increases with age. The most frequent components of the metabolic syndrome were abdominal obesity (71%), arterial hypertension (45%), hypo HDL-cholesterol.

Conclusion: our results show a high prevalence of MS and its main components which are abdominal obesity, arterial hypertension, hypo HDL-cholesterol, explaining in parallel a high level of cardiovascular risk. Management should be multidisciplinary to optimize the risk of chronic complications.

References

Punthakee Z, Goldenberg R, Katz P. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. Canadian Journal of Diabetes. 2018;42:S10-S15. doi:10.1016/j.jcjd.2017.10.003

Zampaligré I. Profil épidémiologique du syndrome métabolique chez les volontaires au dépistage du diabète sucré dans la ville de Bobo-Dioulasso (Burkina Faso).

Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort - PubMed. Accessed May 18, 2023.

Masson E. Nouveaux mécanismes physiopathologiques du Syndrome Métabolique : implication des récepteurs nucléaires orphelins ? EM-Consulte. Accessed March 1, 2025.

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes - PubMed. Accessed March 1, 2025.

Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors | BMC Public Health | Full Text. Accessed March 1, 2025.

Nsiah K, Shang Vo, Boateng Ka, Mensah F. Prevalence of metabolic syndrome in type 2 diabetes mellitus patients. Int J App Basic Med Res. 2015;5(2):133. doi:10.4103/2229-516X.157170

Ferrannini E. Physiological and metabolic consequences of obesity. Metabolism. 1995;44(9 Suppl 3):15-17. doi:10.1016/0026-0495(95)90313-5

Protéine C-réactive, syndrome métabolique et risque d’événements cardiovasculaires incidents : suivi de 8 ans de 14 719 femmes américaines initialement en bonne santé - PubMed. Accessed March 1, 2025.

Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356-359. doi:10.1001/jama.287.3.356

Pietzsch J, Julius U, Nitzsche S, Hanefeld M. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance. Diabetes. 1998;47(12):1928-1934. doi:10.2337/diabetes.47.12.1928

Impact de 4 définitions différentes utilisées pour l’évaluation de la prévalence du syndrome métabolique dans les soins de santé primaires : Projet allemand sur les risques métaboliques et cardiovasculaires (GEMCAS) - PMC. Accessed March 1, 2025.

Osuji CU, Nzerem BA, Dioka CE, Onwubuya EI. Metabolic syndrome in newly diagnosed type 2 diabetes mellitus using NCEP-ATP III, the Nnewi experience. Nigerian Journal of Clinical Practice. 2012;15(4):475. doi:10.4103/1119-3077.104530

Islam MdS, Wei P, Suzauddula M, et al. The interplay of factors in metabolic syndrome: understanding its roots and complexity. Molecular Medicine. 2024;30(1):279. doi:10.1186/s10020-024-01019-y

Kahn R, Buse J, Ferrannini E, Stern M. The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28(9):2289-2304. doi:10.2337/diacare.28.9.2289

Jaspers Faijer-Westerink H, Kengne AP, Meeks KAC, Agyemang C. Prevalence of metabolic syndrome in sub-Saharan Africa: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2020;30(4):547-565. doi:10.1016/j.numecd.2019.12.012

Paramètre anthropométrique permettant de mieux prédire le syndrome métabolique dans le sud-ouest du Nigéria - PubMed. Accessed January 16, 2025.

Annani-Akollor ME, Laing EF, Addai-Mensah O, Fondjo LA, Adu EA, Owiredu EW. Population-derived cut-off for HbA1c could enhance the identification of metabolic syndrome among non-diabetic population. Heliyon. 2020;6(8):e04583. doi:10.1016/j.heliyon.2020.e04583

Ménopause et syndrome métabolique chez la femme tunisienne - Ben Ali - 2014 - BioMed Research International - Wiley Online Library. Accessed January 16, 2025.

Abourazzak F, Talbi S, Lazrak F, et al. Does metabolic syndrome or its individual components affect pain and function in knee osteoarthritis women? Curr Rheumatol Rev. Published online May 21, 2015.

Okafor CI. The metabolic syndrome in Africa: Current trends. Indian J Endocrinol Metab. 2012;16(1):56-66. doi:10.4103/2230-8210.91191

Prévalence du syndrome métabolique et différences entre les sexes - PubMed. Accessed March 1, 2025.

W Z, M AE, Y Z, et al. Metabolic Syndrome, Independent Predictor for Coronary Artery Disease. Clinical laboratory. 2015;61(10). doi:10.7754/clin.lab.2015.150219

Acidocétose chez les diabétiques de type 1 : 73 cas à Dakar - PubMed. Accessed March 1, 2025.

Vg A, Vi B, An P, et al. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study. Diabetes, obesity & metabolism. 2005;7(4). doi:10.1111/j.1463-1326.2004.00409.x

Acidocétose chez les diabétiques de type 1 : 73 cas à Dakar - PubMed. Accessed March 1, 2025.

Khadilkar A, Oza C, Mondkar SA. Insulin Resistance in Adolescents and Youth With Type 1 Diabetes: A Review of Problems and Solutions. Clinical Medicine Insights Endocrinology and Diabetes. 2023;16:11795514231206730. doi:10.1177/11795514231206730

Cisse F, Mehreza A, Thiam S, Lamkinsi T, Ndiaye A, Samba A, Coly NF, Soumah IY, Diedhiou F, Agossou HHM, Diallo-Agne F, Diatta A, & Sall ND. (2020). Etude de la prevalence du syndrome metabolique dans une population adulte Senegalaise / study of the prevalence of metabolic syndrome in Senegalese population. RAMReS2S - CRUFAOCI, 2(2), 1–7.

Downloads

Published

2025-09-02

Issue

Vol. 7 No. 2 (2025)

Section

Articles

License

Copyright (c) 2025 Suitambaye Noubaramadji Yamti, Abel Dafogo Djibagaou, Koutaya Dezoumbe, Amine Akouya, Zita Aleyo Nodjikouambaye, Andrillene Laure Detou Wondeu, Brahim Boy Otchom, Sabrina Atturo, Giulia Cappelli, Vittorio Colizzi

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with ESHR agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.